Kathleen Ford, Chief Operating Officer at Kura Oncology, Inc. (KURA), sold 1,558 shares at $6.28 ($10K) on 2025-05-19, disclosed to the SEC on 2025-05-19.
Scheduled sale ($10k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KURA | SELL | 2026-01-27 | $15K | — | Filing → |
| KURA | SELL | 2025-11-14 | $154K | — | Filing → |
| KURA | SELL | 2025-09-29 | $123K | — | Filing → |